Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/206161
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial |
Autor: | Kjølbæk, Louise; Benítez-Páez, Alfonso CSIC ORCID ; Gómez del Pulgar, Eva M. CSIC ORCID; Brahe, L.K.; Liebisch, G.; Matysik, S.; Rampelli, S.; Vermeiren, J.; Brigidi, P.; Larsen, L.H.; Astrup, A.; Sanz Herranz, Yolanda CSIC ORCID | Palabras clave: | Gut microbiota Arabinoxylan oligosaccharide Fiber Fish oil Metabolic syndrome |
Fecha de publicación: | 19-feb-2019 | Editor: | Elsevier | Citación: | Clinical Nutrition 39 (1): 67-79 | Resumen: | Background & aims: Gut microbiota composition is linked to obesity and metabolic syndrome. The nutrients and doses required to modulate the gut microbiota towards beneficially influence components of the metabolic syndrome are unclear. This study aimed to investigate diet-induced effects on the gut microbiota and metabolic markers in overweight individuals with indices of the metabolic syndrome. Methods: A twelve-week randomized cross-over trial was conducted with two intervention periods separated by a washout period. The dietary intakes of interest were wheat bran extract, rich in arabinoxylan oligosaccharides (AXOS) (10.4 g/d AXOS) and polyunsaturated fatty acids (PUFA) (3.6 g/d n-3 PUFA). Dietary records, fecal and blood samples, as well as anthropometric data, were collected before and after intervention. Anthropometry and gastrointestinal symptoms were evaluated weekly. Gut microbiota composition was analyzed by massive sequencing of 16S ribosomal RNA gene V3V4 amplicons. Results: Twenty-seven participants completed the study (90%). Intake of AXOS induced an expected bifidogenic effect on gut microbiota (p < 0.01) and increased butyrate-producing bacterial species as well (p < 0.05). Beta-diversity analysis indicated that the structure of the gut microbiota only changed as a result of the AXOS intervention (Permanova = 1.90, p < 0.02) and no changes in metabolic markers were observed after any of the interventions. Conclusions: AXOS intake has a bifidogenic effect and also increases butyrate producers in the gut microbiota; even though this type of dietary fiber did not modulate lipid or glucose metabolic parameters related to metabolic syndrome. Four-week PUFA intake did not induce any notable effect on the gut microbiota composition or metabolic risk markers. | Versión del editor: | https://doi.org/10.1016/j.clnu.2019.01.012 | URI: | http://hdl.handle.net/10261/206161 | DOI: | 10.1016/j.clnu.2019.01.012 | ISSN: | 0261-5614 |
Aparece en las colecciones: | (IATA) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Clinical Nutrition2020-39_67-79.pdf | Artículo principal | 1,37 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
65
checked on 16-abr-2024
WEB OF SCIENCETM
Citations
57
checked on 28-feb-2024
Page view(s)
150
checked on 18-abr-2024
Download(s)
1.081
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons